News
JP Morgan Maintains Overweight on Cogent Biosciences, Raises Price Target to $20
27 Feb 24
News, Price Target, Analyst Ratings
Citigroup Maintains Buy on Cogent Biosciences, Raises Price Target to $13
26 Feb 24
News, Price Target, Analyst Ratings
Cogent Biosciences Q4 EPS $(0.63) Down From $(0.56) YoY
26 Feb 24
Earnings, News
12 Health Care Stocks Moving In Monday's Pre-Market Session
26 Feb 24
Movers
Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target
26 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Maintains Neutral on Cogent Biosciences, Raises Price Target to $10
23 Feb 24
News, Price Target, Analyst Ratings
Cogent Biosciences Announces Part 1b Data From SUMMIT Trial Evaluating Bezuclastinib In Patients With Nonadvanced Systemic Mastocytosis; 51% Week 12 Mean Change In Total Symptom Score, Including 70% Of Patients Achieving ≥50% Reduction In TSS At Week 12
22 Feb 24
Biotech, News, General
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
14 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's Intraday Session
14 Feb 24
Movers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
14 Feb 24
Movers
Needham Reiterates Buy on Cogent Biosciences, Maintains $15 Price Target
12 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Citigroup Initiates Coverage On Cogent Biosciences with Buy Rating, Announces Price Target of $11
8 Feb 24
News, Price Target, Initiation, Analyst Ratings
12 Health Care Stocks Moving In Wednesday's After-Market Session
10 Jan 24
Movers
Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib, Emerging Portfolio of Selective and Potent Targeted Therapeutics
9 Jan 24
Biotech, News, Health Care, General
Press releases
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
26 Feb 24
Earnings, Press Releases
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
22 Feb 24
Press Releases
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
14 Feb 24
Press Releases
Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
2 Jan 24
News, Press Releases